Personalized High-Definition Transcranial Direct Current Stimulation for the Treatment of Depression: A Randomized...

Area of Science:

• Neuroscience
• Psychiatry
• Medical Devices

Background:

• Transcranial direct current stimulation (tDCS) is a promising depression treatment.
• Personalized, focal high-definition tDCS (HD-tDCS) may improve therapeutic outcomes.
• Investigating HD-tDCS for depression is crucial due to its precision.

Purpose of the Study:

• To determine if HD-tDCS therapy improves mood in moderate to severe depression patients.
• To assess the efficacy of a 12-day HD-tDCS regimen.
• To evaluate the safety and tolerability of HD-tDCS.

Main Methods:

• A randomized, double-blind, sham-controlled trial involving 71 participants.
• Participants received daily 20-minute sessions of active or sham HD-tDCS for 12 consecutive days.
• Personalized HD-tDCS configurations were created using MRI and neuronavigation.

Main Results:

• Active HD-tDCS significantly improved Hamilton Depression Rating Scale (HAMD) scores compared to sham (group difference: -2.2; P=.04).
• Greater reductions in HAMD scores were observed in the active treatment group (-7.8) versus the sham group (-5.6).
• HD-tDCS was well-tolerated with minimal adverse effects; exploratory analysis suggested benefits for anxiety symptoms.

Conclusions:

• A 12-day course of HD-tDCS significantly improved mood in moderate to severe depression with a moderate effect size.
• HD-tDCS demonstrates potential for rapid antidepressant effects compared to other therapies.
• Further research is needed to confirm long-term efficacy and optimize HD-tDCS protocols for depression and anxiety.